CAFs and TGF-β Signaling Activation by Mast Cells Contribute to Resistance to Gemcitabine/Nabpaclitaxel in Pancreatic Cancer
- Supplementary File 1:
PDF-Document (PDF, 142 KiB)
Porcelli, L.; Iacobazzi, R.M.; Di Fonte, R.; Serratì, S.; Intini, A.; Solimando, A.G.; Brunetti, O.; Calabrese, A.; Leonetti, F.; Azzariti, A.; Silvestris, N. CAFs and TGF-β Signaling Activation by Mast Cells Contribute to Resistance to Gemcitabine/Nabpaclitaxel in Pancreatic Cancer. Cancers 2019, 11, 330.
Porcelli L, Iacobazzi RM, Di Fonte R, Serratì S, Intini A, Solimando AG, Brunetti O, Calabrese A, Leonetti F, Azzariti A, Silvestris N. CAFs and TGF-β Signaling Activation by Mast Cells Contribute to Resistance to Gemcitabine/Nabpaclitaxel in Pancreatic Cancer. Cancers. 2019; 11(3):330.
Chicago/Turabian StylePorcelli, Letizia; Iacobazzi, Rosa M.; Di Fonte, Roberta; Serratì, Simona; Intini, Angelica; Solimando, Antonio G.; Brunetti, Oronzo; Calabrese, Angela; Leonetti, Francesco; Azzariti, Amalia; Silvestris, Nicola. 2019. "CAFs and TGF-β Signaling Activation by Mast Cells Contribute to Resistance to Gemcitabine/Nabpaclitaxel in Pancreatic Cancer" Cancers 11, no. 3: 330.